Free Trial
→ Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (From Behind the Markets) (Ad) Buy SLNCF Stock  Free SLNCF Stock Alerts

Silence Therapeutics (SLNCF) SEC Filings & 10K Form

Silence Therapeutics logo
$0.97 0.00 (0.00%)
As of 05/22/2025
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/21/2025
5:49 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:12 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/20/2025
3:14 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
5:05 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form DEF 14A
05/16/2025
5:07 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form ARS
05/15/2025
8:02 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13G/A
05/08/2025
9:18 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
05/08/2025
7:10 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:35 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:08 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:03 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:06 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form PRE 14A
05/02/2025
9:28 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:13 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
5:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:28 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
04/24/2025
6:16 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
9:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
1:17 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:47 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:50 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
03/06/2025
10:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:20 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:30 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
9:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:03 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13G
02/11/2025
5:41 PM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13G/A
01/02/2025
3:32 PM		HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:34 PM		Davidson Michael H. (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:36 PM		Ede-Golightly James (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:38 PM		Ross Iain (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:39 PM		Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
TOOMAN CRAIG A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:43 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:00 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:32 PM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump Predicts Dollar Downfall (Ad)

READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?

Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now.
10/22/2024
4:20 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form F-3ASR
08/15/2024
8:05 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
5:51 PM		Invus Global Management, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
06/27/2024
6:40 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:38 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:41 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:SLNCF) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...
Paradigm Press | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored